Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial (Q56974767)
Jump to navigation
Jump to search
scientific article published on 03 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial |
scientific article published on 03 January 2014 |
Statements
Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial (English)
Francesco Travaglino
Veronica Russo
Benedetta De Berardinis
Filippo Numeroso
Pamela Catania
Stefano Geniere Nigra
Francesco Geraci
Maria Antonietta Bressan
Stefania Guerrini
Mario Cavazza
Christian Folli
Valter Monzani
Stefania Battista
Giulio Mengozzi
Paola Noto
Giuseppe Carpinteri
Federica Stella
Stella Ingrassia
Paolo Moscatelli
Patrizia Giuntini
Gerardo Salerno
Patrizia Cardelli
Salvatore Di Somma